COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1924: Articles 19231-19240  | Next

The association of covid-19 infection with household food insecurity among Iranian population
Kalantari, N., Ezzeddin, N., Eini-Zinab, H.
10.1101/2020.12.15.20248221 — Posted: 2020-12-16
Utility of COVID-19 Decision Rules Related to Consecutive Decline in Positivity or Hospitalizations: A Data-driven Simulation Study
Ejima, K., Maki, K., Golzarri-Arroyo, L., Allison, D. B.
10.1101/2020.12.14.20248190 — Posted: 2020-12-16
Investigating mental and physical disorders associated with COVID-19 in online health forums
Patel, R., Smeraldi, F., Abdollahyan, M., Irving, J., Bessant, C.
10.1101/2020.12.14.20248155 — Posted: 2020-12-16
Comparison of Healthcare costs and benefits of the UK's Covid-19 response with four European countries: Decision Modelling Study
Thom, H., Walker, J., Vickerman, P., Hollingworth, W.
10.1101/2020.12.14.20248201 — Posted: 2020-12-16
Amplicon contamination in labs masquerades as COVID19 in surveillance tests
Davidi, D., Fitzgerald, S., Glaspell, H. L., Jalbert, S., Maheras, S., Mattoon, S. E., Britto, V. M., Hamer, D. H., Nguyen, G. T., Platt, J., Stuopis, C. W., Turse, J. E., Springer, M.
10.1101/2020.12.08.20244525 — Posted: 2020-12-15
Genomic diversity analysis of SARS-CoV-2 genomes in Rwanda
Lambert, N., Pacifique, N., Zakham, F.
10.1101/2020.12.14.422793 — Posted: 2020-12-15
No detectable signal for ongoing genetic recombination in SARS-CoV-2
Richard, D., Owen, C. J., van Dorp, L., Balloux, F.
10.1101/2020.12.15.422866 — Posted: 2020-12-15
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Rouet, R., Mazigi, O., Walker, G. J., Langley, D. B., Sobti, M., Schofield, P., Lenthall, H., Jackson, J., Ubiparipovic, S., Henry, J. Y., Abayasingam, A., Burnett, D., Kelleher, A., Brink, R., Bull, R. A., Turville, S., Stewart, A. G., Goodnow, C. C., Rawlinson, W. D., Christ, D.
10.1101/2020.12.14.422791 — Posted: 2020-12-15
A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics
Gossen, J., Albani, S., Hanke, A., Joseph, B. P., Bergh, C., Kuzikov, M., Costanza, E., Manelfi, C., Storici, P., Gribbon, P., Beccari, A. R., Talarico, C., Spyrakis, F., Lindahl, E., Zaliani, A., Carloni, P., Wade, R. C., Musiani, F., Kokh, D. B., Rossetti, G.
10.1101/2020.12.14.422634 — Posted: 2020-12-15
Transfer Learning with MotifTransformers for Predicting Protein-Protein Interactions Between a Novel Virus and Humans
Lanchantin, J., Sekhon, A., Miller, C. L., Qi, Y.
10.1101/2020.12.14.422772 — Posted: 2020-12-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).